Our research unit examines the interaction of immune cells with leukemia and cancer cells. The main research focus is to analyze so-called cancer/leukemia stem cells. These cells are the origin of the disease and are responsible for relapse after successful chemotherapy. The aim of our research is to develop improved immunotherapies for different types of cancer. The studies are performed in preclinical mouse models and using primary patient material and humanized mouse models. Therefore, our studies generate broad understanding of translational research from animal studies to clinical application.
Please visit the external Group Website for more information.